HOME >> MEDICINE >> NEWS
New use of 64-slice CT scan to be studied at HUP to help diagnose coronary artery disease in the ED

tient comes into the ED complaining of chest pain, an EKG is performed, blood tests are done, the pain is treated and then the patient is admitted to the hospital for further testing to make sure they are not having a heart attack," explains Harold Litt, MD, PhD, Chief of Cardiovascular Imaging in Radiology at HUP. "But now, after assessing the likelihood that it's actually coronary artery disease causing the chest pain -- based on family history and other factors -- low-risk patients can have this CT scan quickly, and within two to three hours of arriving in the ED, we can tell whether or not the patient has coronary disease and needs to stay in the hospital or if he can be sent home. The test itself takes only about five minutes, and can also show us many causes of chest pain not related to the heart."

"In the end, we hope to find patients that we can send home right away because nearly 85 percent don't have ischemic coronary artery disease," said Judd Hollander, MD, the emergency medicine physician leading the study at HUP. "This is useful to Emergency Department physicians to find the 15 percent who actually do."

William Baxt, MD, Chair of the Department of Emergency Medicine at Penn, adds, "This utilization of multi-slice CT in the ED may help us catch the patients who we might have initially thought were safe to go home, but they're not. They need further treatment and observation for heart disease."

Dr. Baxt further explains, "On the other side, this potentially could save society vast amounts of money by foregoing unnecessary admission into hospitals for further testing. Also, more beds as well as emergency medicine personnel would be available to treat the really ill patients who need care."


'"/>

Contact: Susanne Hartman
susanne.hartman@uphs.upenn.edu
215-349-5964
University of Pennsylvania School of Medicine
29-Sep-2005


Page: 1 2

Related medicine news :

1. Spinal manipulation in children studied
2. New blood thinner studied for patients with leg and lung clots
3. ACTOS (pioglitazone HCl) to be studied in new trial
4. Use of high hydrostatic pressure to inactivate Hepatitis A virus in oysters studied
5. Long-term outcomes studied for stem cell transplant recipients
6. New treatments for common vaginal infection being studied
7. RAND finds cases of undiagnosed diabetes drop sharply
8. New Mayo Clinic MRI technology enables noninvasive liver diagnoses
9. Breast MRI may help determine surgical management of women with newly diagnosed breast cancer
10. Electronic nose may help diagnose asthma
11. New blood test can diagnose and monitor treatment of Parkinsons disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/20/2017)... ... June 20, 2017 , ... Caduceus ... is pleased to announce a new online course entitled Personal & Community ... insights and evidence-based strategies for achieving optimal well-being and teaches students how to ...
(Date:6/20/2017)... ... 20, 2017 , ... Fresenius Vascular Care, a national network of outpatient vascular ... manage a wide range of vascular conditions, has today announced its new name, Azura ... represented by more than 40 local brands, a phased rollout of the new brand ...
(Date:6/20/2017)... (PRWEB) , ... June 20, 2017 , ... ... report contending that the introduction of school choice can promote economic development in ... charter school that has, according to the report, contributed to the economic development ...
(Date:6/20/2017)... ... June 20, 2017 , ... AMC Health , ... and success in the clinical trials market. Similar to its approach in demonstrating positive ... the clinical trials marketplace by proving the value of eVisits to support virtual studies. ...
(Date:6/20/2017)... ... June 20, 2017 , ... Leading dental clinicians, Drs. Ashlyn ... with the VATECH PaX-i and Anatomage systems. With advanced digital images and modeling capabilities, ... place dental implants precisely and restore oral health for those who are missing ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... Inc., (Nasdaq: NVAX ) today announced that data ... RSV F protein recombinant nanoparticle vaccine candidate (RSV F Vaccine) ... the journal Vaccine (the data contained ... The Company previously announced top line results from ... F Vaccine with the goal of protecting infants from RSV ...
(Date:6/3/2017)... , June 3, 2017  Eli Lilly ... announced that results from the Phase 3 MONARCH ... (CDK)4 & 6 inhibitor, in combination with fulvestrant, ... with fulvestrant alone in women with hormone-receptor-positive (HR+), ... breast cancer who have relapsed or progressed after ...
(Date:5/30/2017)... 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), will present ... Conference on Tuesday, June 13, 2017, in Rancho ... president and chief executive officer, is scheduled to present at ... can be accessed at http://ir.hill-rom.com/events.cfm . A recorded replay ... event through September 13, 2017. ...
Breaking Medicine Technology:
Cached News: